ThinkstockShares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) sank on Monday after the company announced that there will be an interruption in the supply of Auryxia (ferric citrate) tablets due to a production-related issue converting active…
Verizon Communications is continuing its campaign to diversify its businesses with its most recent acquisition of Fleetmatics.
Shares of Biogen and, especially, Ionis Pharmaceuticals made handy gains early Monday morning following favorable interim results from a late-stage trial.
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results this week.
Although Alphabet underperformed in its first-quarter earnings report, the second-quarter report more than made up for it by pushing shares to just under their all-time highs.
Gilead Sciences reported its earnings on Monday of last week, and since that time there has been much analyst activity around the stock.
Facebook blew investors away with stellar earnings this quarter, impressing on both the top and bottom line, which helped its shares break through to hit a new all-time high.
The recent performance from Gilead Sciences has analysts and investors concerned about the future. Argus believes that the headwinds are blowing harder than the tailwinds for the company.
Shares of Seres Therapeutics took an absolute dive early in Friday’s session as the company stared down the barrel of a seemingly failed mid-stage clinical trial.
With this earnings report, Chevron is continuing to make progress toward its goal of getting cash balanced. However, recent slumping oil prices have put a damper on the stock.
AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.
Amazon.com absolutely blew out earnings, with an incredible beat on the bottom line and a solid beat on the top line.
Exxon Mobil is expected to release its most recent earnings report before the markets open on Friday.
Chevron is scheduled to report its second-quarter financial results before the markets open on Friday.
Operational performance in the second quarter was strong across the ConocoPhillips portfolio, although not strong enough to keep it from posting a net loss.
In its most recent earnings report, Alphabet underperformed, but overall analysts called it a good quarter. Hopefully, the company can post a win with the latest results.
Amazon.com is scheduled to report its second-quarter financial results after the markets close on Thursday.
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
Overall, investors were content after Celgene reported its second-quarter financial results, with wins on both the top and bottom lines.
Whole Foods Markets reported fiscal third-quarter financial results after markets closed on Wednesday.
